Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA accepts Cardurion's IND for phase I study of CRD-733

Sep. 21, 2018

Further studies planned after first-in-human trial of respiratory disease candidate OATD-01

Sep. 21, 2018

First patient enrolled in phase IIa HIV study of GnRH agonist ISR-048

Sep. 21, 2018

First patient treated in phase I trial of BAY-1905254

Sep. 21, 2018

PET tracer for renal imaging tested in vivo

Sep. 21, 2018

IRLAB announces updates to its pipeline

Sep. 21, 2018

Hulio, a biosimilar to adalimumab, receives marketing authorization in Europe

Sep. 21, 2018

Global phase III ALPS study of roxadustat meets primary endpoints

Sep. 21, 2018

Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical discover MAP3K5 inhibitors

Sep. 21, 2018

Hadasit Medical Research Services and Development, Ramot patent glycogen synthase inhibitors

Sep. 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...